Addus HomeCare Corporation (ADUS) Dividend Safety Gauge & 10-Year DRIP Compounder

Per the Roarable RQD rating, ADUS carries an RQD Score of 73, a letter grade of B, and the verdict label "Roarable Buy — Good Risk/Reward." The five pillars are:

• Fundamental Cash Engine: 12 / 20. Per the RQD rating, this pillar cites ROIC of 9.1% and FCF yield of 4.47%. This is the lowest-scoring pillar, indicating that cash generation relative to capital and valuation is only moderately supportive of the thesis. An investor should note that the FCF yield of 4.47% is the main valuation anchor for cash-based reasoning.
• Whale 13F Flow: 16 / 20. The RQD rating describes institutional accumulation and options positioning as a relative strength. This suggests larger holders have been net constructive, though the holder-level data supporting this pillar is not itemized in the source data.
• Insider Conviction: 15 / 20. Per the RQD rating, SEC Form 4 and Congressional PTR cluster flow contribute a moderately positive signal. The underlying transaction detail is not itemized in the source data.
• Macro Regime Fit: 15 / 20. Per the RQD rating, beta is 1.0 and sector sensitivity is cited. A beta of 1.0 means the stock is described as moving in line with the broad market, so macro regime shifts would be expected to affect it roughly proportionally.
• Forensic Balance Sheet: 15 / 20. Per the RQD rating, Altman Z is 5.83, Piotroski F is 9/9, and Debt/Equity is 0.11. These are the strongest forensic readings in the source data and point to a low-leverage, financially sound profile.

For a prospective investor evaluating the stock today, the pillar mix implies that the case rests more on balance sheet strength and institutional/insider positioning than on cash-generation efficiency. Valuation is a tradeoff: per the market data, P/E (TTM) is 24.2 versus a forward P/E of 20.3, which implies expected earnings growth is embedded in the forward estimate, while EV/EBITDA of 16.8 is not compared to a peer benchmark in the source data. The upside drivers cited are the forensic strength and positioning flow; the main constraint is the 9.1% ROIC and 4.47% FCF yield. Ripple effects from the sector are not quantified in the source data. This analysis is educational and not personalized financial advice.

Per the recent news feed, all six items are flagged YELLOW and classified as MARKET WIRE, sourced from Yahoo Finance, TradingView, Simply Wall St, and Stock Traders Daily. Themes include market action and institutional positioning coverage, a Q3 earnings preview, and an announcement of a Third Quarter 2026 earnings release and conference call. Headlines are general market commentary; no specific operational, contract, or regulatory catalyst is detailed in the source summaries. Risk watch items: the upcoming Q3 earnings release is the one dated event named in the feed. Proprietary signals: Not available in source data, per the Butterfly Supply-Chain Graph.

• What are the specific service lines and payer mix behind FY 2025 revenue growth, and how much depends on government reimbursement?
• What are the reported EPS and cash balances for FY 2025 and FY 2023, which are currently marked as unavailable?
• What is the composition and timing of the institutional, insider, and Congressional transactions underlying the RQD pillar scores?
• How does EV/EBITDA of 16.8 and ROIC of 9.1% compare with peers, given no peer or analyst benchmark is included in the source data?
• What drove the decline in FCF from $112.2M to $103.8M despite rising net income?